ICT Spend Predictions in Small Chinese Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
This report illustrates how Kable expects Small Chinese Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.
Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company’s demographic profile. The statistical model has been developed using an extensive collection of survey and interview data that Kable has conducted with ICT decision makers on their ICT spending, as well as the insight of our analyst team.
What makes this report unique and essential to read? The predictions were formulated in November 2012 following a large survey of ICT decision makers. Estimated trends in ICT spending have been identified through to the end of 2013 following feedback from respondents on their forthcoming investment plans.
Understand how the Small Chinese Pharmaceutical Companies are allocating their external ICT budgets.
Gain a view as to how Small Chinese Pharmaceutical Companies ICT budgets are being allocated by IT function.
Understand how Small Chinese Pharmaceutical Companies ICT budgets are being allocated across internal and external entities.
Get a detailed breakdown of Small Chinese Pharmaceutical Companies estimated budget allocation within each of the core areas of ICT spend (hardware, software, IT Services, telecommunications & consulting).